Asahi Kasei Corp. offered to buy Aicuris Anti-infective Cures AG, expanding its infectious disease portfolio with a marketed cytomegalovirus product and a herpes treatment nearing an NDA.

Researchers from Synklino A/S have published preclinical data supporting the potential of SYN-002, a targeted antiviral therapy that eliminates human cytomegalovirus (HCMV)‑infected cells by ...

Wuppertal, Germany, February 26, 2026 - Aicuris Anti-infective Cures AG (“Aicuris”) today announced that it has entered into a definitive ...

Preclinical data demonstrate >90% reduction in human cytomegalovirus (HCMV) reactivation from latency, establishing proof-of-concept for ...

Preclinical data demonstrate >90% reduction in human cytomegalovirus (HCMV) reactivation from latency, establishing proof-of-concept for SYN002 in human kidneysData published in the American Journal o ...

A new study found that people with cytomegalovirus (CMV) infection may be more likely to develop systemic lupus erythematosus (SLE), and CMV could influence how the disease starts.

The Manitoba government has expanded universal newborn screening to include congenital cytomegalovirus (cCMV), making Manitoba one of the first Canadian jurisdictions to test all newborns for a ...

Manitoba has begun universal screening for congenital cytomegalovirus (cCMV) in all newborns with the aim of early detection ...

The Manitoba government has expanded its newborn screening program to include congenital cytomegalovirus (cCMV), a leading ...

More than 1,500 newborns in Manitoba have been screened for a congenital virus that can cause birth defects since last ...

Manitoba has become the third jurisdiction in Canada to implement universal newborn screening for congenital cytomegalovirus, ...

Researchers say an immunotherapy they used represents a significant step forward and could lead to new treatment options, even for other forms of cancer ...